作者: Eamonn M.M. Quigley
DOI: 10.1016/J.GTC.2012.08.005
关键词:
摘要: Irritable bowel syndrome (IBS) and chronic constipation (CC) are common problems worldwide associated with significant impact on activities of daily living quality life. Recent interest, in IBS particular, has focused the potential roles microbiota its interaction host's immune system. Recently, high-quality clinical trials have been performed prebiotics probiotics or CC. Although strategies that seek to modify microbiota, such as use probiotics, offer much promise CC, more and, studies longer duration required.